Found: 15
Select item for more details and to access through your institution.
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.
- Published in:
- Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-024-00703-x
- By:
- Publication type:
- Article
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
- Published in:
- CA: A Cancer Journal for Clinicians, 2023, v. 73, n. 6, p. 620, doi. 10.3322/caac.21785
- By:
- Publication type:
- Article
Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00626
- By:
- Publication type:
- Article
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02332-2
- By:
- Publication type:
- Article
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01150-4
- By:
- Publication type:
- Article
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1457, doi. 10.1634/theoncologist.2020-0610
- By:
- Publication type:
- Article
Neoadjuvant immunotherapy for advanced, resectable non–small cell lung cancer: A systematic review and meta‐analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 13, p. 1969, doi. 10.1002/cncr.34755
- By:
- Publication type:
- Article
Beyond chemotherapy: Emerging biomarkers and therapies as small cell lung cancer enters the immune checkpoint era.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer.
- Published in:
- Cancer & Metabolism, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40170-021-00270-9
- By:
- Publication type:
- Article
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26821-8
- By:
- Publication type:
- Article
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
- Published in:
- Molecular Cancer, 2024, v. 23, p. 1, doi. 10.1186/s12943-024-02014-x
- By:
- Publication type:
- Article
Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.757323
- By:
- Publication type:
- Article
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215589, doi. 10.1001/jamanetworkopen.2022.15589
- By:
- Publication type:
- Article
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. 1, doi. 10.1001/jamanetworkopen.2022.15589
- By:
- Publication type:
- Article
Giving AXL the axe: targeting AXL in human malignancy.
- Published in:
- 2017
- By:
- Publication type:
- journal article